These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 9475276)

  • 1. Effect of JTV-506, a novel vasodilator, on experimental angina model in rats.
    Hirata Y; Miyai H; Mabuchi Y; Aisaka K
    J Cardiovasc Pharmacol; 1998 Feb; 31(2):322-6. PubMed ID: 9475276
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of JTV-506, a novel vasodilator, on coronary blood flow in conscious dogs.
    Hirata Y; Aisaka K
    J Cardiovasc Pharmacol; 1997 Mar; 29(3):397-405. PubMed ID: 9125679
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of KRN2391, a novel vasodilator, on various experimental anginal models in rats.
    Harada K; Fukata Y; Miwa A; Kaneta S; Fukushima H; Ogawa N
    Jpn J Pharmacol; 1993 Sep; 63(1):35-9. PubMed ID: 8271529
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of the new potassium channel opener JTV-506 on coronary vessels in vitro and in vivo.
    Hirata Y; Kanada A; Miyai H; Mabuchi Y; Aisaka K
    Arzneimittelforschung; 1999 Mar; 49(3):199-206. PubMed ID: 10219462
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cardiovascular pharmacological studies on JTV-506, a new potassium channel opener. 2nd communication: effects on blood pressure in conscious animals.
    Hirata Y; Suzuki Y; Miyai H; Aisaka K
    Arzneimittelforschung; 2000 Apr; 50(4):333-40. PubMed ID: 10800631
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Systemic and coronary hemodynamic effects of JTV-506, a novel potassium channel opener, in conscious dogs: comparison with cromakalim and nicorandil.
    Zhang S; Sakai K; Hasuo H; Furuta K; Ureshino H; Shibata O; Sumikawa K
    Res Commun Mol Pathol Pharmacol; 1999; 105(1-2):115-27. PubMed ID: 10850375
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antianginal effects of lercanidipine on the vasopressin or methacholine induced anginal model in rats.
    Sasaki T; Maruyama H; Kase Y; Takeda S; Aburada M
    Biol Pharm Bull; 2005 May; 28(5):811-6. PubMed ID: 15863884
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Analysis of relaxation and repolarization mechanisms of nicorandil in rat mesenteric artery.
    Fujiwara T; Angus JA
    Br J Pharmacol; 1996 Dec; 119(8):1549-56. PubMed ID: 8982500
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Enhancement of the vasodepressor response to adenosine by nicorandil in rats: comparison with cromakalim.
    Saito K; Sakai K
    Fundam Clin Pharmacol; 1998; 12(1):37-43. PubMed ID: 9523182
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antianginal and anti-ischemic efficacy of nicorandil compared with nifedipine in patients with angina pectoris and coronary heart disease: a double-blind, randomized, multicenter study.
    Ulvenstam G; Diderholm E; Frithz G; Gudbrandsson T; Hedbäck B; Höglund C; Moelstad P; Perk J; Sverrisson JT
    J Cardiovasc Pharmacol; 1992; 20 Suppl 3():S67-73. PubMed ID: 1282179
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Nicorandil. A review of its pharmacology and therapeutic efficacy in angina pectoris.
    Frampton J; Buckley MM; Fitton A
    Drugs; 1992 Oct; 44(4):625-55. PubMed ID: 1281076
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Synthesis and selective coronary vasodilatory activity of 3,4-dihydro-2,2-bis(methoxymethyl)-2H-1-benzopyran-3-ol derivatives: novel potassium channel openers.
    Cho H; Katoh S; Sayama S; Murakami K; Nakanishi H; Kajimoto Y; Ueno H; Kawasaki H; Aisaka K; Uchida I
    J Med Chem; 1996 Sep; 39(19):3797-805. PubMed ID: 8809167
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A double-blind comparison of a beta-blocker and a potassium channel opener in exercise induced angina.
    Raftery EB; Lahiri A; Hughes LO; Rose EL
    Eur Heart J; 1993 Jul; 14 Suppl B():35-9. PubMed ID: 8370371
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Efficacy of nicorandil versus propranolol in mild stable angina pectoris of effort: a long-term, double-blind, randomized study.
    Meeter K; Kelder JC; Tijssen JG; Bucx JJ; Henneman JA; Kerker JP; Hugenholtz PG
    J Cardiovasc Pharmacol; 1992; 20 Suppl 3():S59-66. PubMed ID: 1282178
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of KRN2391, nicorandil and diltiazem on the changes in the electrocardiogram caused by endothelin-1 in anaesthetized rats.
    Harada K; Miwa A; Kaneta S; Izawa T; Fukushima H; Ogawa N
    Br J Pharmacol; 1993 Jul; 109(3):679-84. PubMed ID: 7689399
    [TBL] [Abstract][Full Text] [Related]  

  • 16. New antianginal nitro esters with reduced hypotensive activity. Synthesis and pharmacological evaluation of 3-[(nitrooxy)alkyl]-2H-1,3-benzoxazin-4(3H)-ones.
    Benedini F; Bertolini G; Cereda R; Donà G; Gromo G; Levi S; Mizrahi J; Sala A
    J Med Chem; 1995 Jan; 38(1):130-6. PubMed ID: 7837224
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of KRN4884 (a novel K+ channel opener), levcromakalim, nilvadipine and propranolol on endothelin-1-induced heart disorders in anesthetized rats.
    Harada K; Kawahara J; Okada Y; Uzumaki H; Kusaka M; Tokiwa T
    Jpn J Pharmacol; 1998 Nov; 78(3):261-8. PubMed ID: 9869259
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Role of K+ channel opening and stimulation of cyclic GMP in the vasorelaxant effects of nicorandil in isolated piglet pulmonary and mesenteric arteries: relative efficacy and interactions between both pathways.
    Pérez-Vizcaíno F; Cogolludo AL; Villamor E; Tamargo J
    Br J Pharmacol; 1998 Mar; 123(5):847-54. PubMed ID: 9535012
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of an orally active Na+/H+ exchange inhibitor, SMP-300, on experimental angina and myocardial infarction models in rats.
    Yamamoto S; Matsui K; Sasabe M; Ohashi N
    J Cardiovasc Pharmacol; 2002 Feb; 39(2):234-41. PubMed ID: 11791009
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antianginal effect of RS-5773, a diltiazem congener, in the methacholine-induced anginal model in rats.
    Shiga H; Miyake S; Fukuda N; Yorikane R; Koike H
    Jpn J Pharmacol; 1996 Dec; 72(4):365-74. PubMed ID: 9015745
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.